Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus

The regulation of gene expression is crucial for the normal development and the homeostatic maintenance of body tissues. Thus, its malfunction may determine a variety of human disease conditions. A growing body of evidence has shown the overwhelming relevance of a new class of gene expression regula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cortés,Víctor, Quezada,Nicolás, Rigotti,Attilio, Maiz,Alberto
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2005
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872005001200011
record_format dspace
spelling oai:scielo:S0034-988720050012000112006-01-27Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitusCortés,VíctorQuezada,NicolásRigotti,AttilioMaiz,Alberto Diabetes mellitus Hyperlipidemia Receptors cytoplasmic and nuclear The regulation of gene expression is crucial for the normal development and the homeostatic maintenance of body tissues. Thus, its malfunction may determine a variety of human disease conditions. A growing body of evidence has shown the overwhelming relevance of a new class of gene expression regulators: the heterodimeric nuclear receptors, a family of structurally related proteins involved in multiple biological functions. In response to activating ligands, these molecules bind to specific genomic regulatory regions where they can coordinately modify the transcriptional activity of several genes involved in the main metabolic pathways of lipids and carbohydrates in cells. These functional properties have stimulated the study of the relationships between heterodimeric nuclear receptors and various disease conditions, such as dyslipidemias and diabetes mellitus. Here we review the experimental, clinical and epidemiological evidences that support the relevance of these transcriptional regulators in the pathophysiology of the most prevalent and lethal diseases in Western countries. We also explore the potential therapeutic impact of new strategies based in the pharmacological modulation of the heterodimeric nuclear receptors. (Rev Méd Chile 2005; 133: 1483-92)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.12 20052005-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011es10.4067/S0034-98872005001200011
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Diabetes mellitus
Hyperlipidemia
Receptors
cytoplasmic and nuclear
spellingShingle Diabetes mellitus
Hyperlipidemia
Receptors
cytoplasmic and nuclear
Cortés,Víctor
Quezada,Nicolás
Rigotti,Attilio
Maiz,Alberto
Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
description The regulation of gene expression is crucial for the normal development and the homeostatic maintenance of body tissues. Thus, its malfunction may determine a variety of human disease conditions. A growing body of evidence has shown the overwhelming relevance of a new class of gene expression regulators: the heterodimeric nuclear receptors, a family of structurally related proteins involved in multiple biological functions. In response to activating ligands, these molecules bind to specific genomic regulatory regions where they can coordinately modify the transcriptional activity of several genes involved in the main metabolic pathways of lipids and carbohydrates in cells. These functional properties have stimulated the study of the relationships between heterodimeric nuclear receptors and various disease conditions, such as dyslipidemias and diabetes mellitus. Here we review the experimental, clinical and epidemiological evidences that support the relevance of these transcriptional regulators in the pathophysiology of the most prevalent and lethal diseases in Western countries. We also explore the potential therapeutic impact of new strategies based in the pharmacological modulation of the heterodimeric nuclear receptors. (Rev Méd Chile 2005; 133: 1483-92)
author Cortés,Víctor
Quezada,Nicolás
Rigotti,Attilio
Maiz,Alberto
author_facet Cortés,Víctor
Quezada,Nicolás
Rigotti,Attilio
Maiz,Alberto
author_sort Cortés,Víctor
title Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
title_short Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
title_full Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
title_fullStr Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
title_full_unstemmed Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
title_sort nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus
publisher Sociedad Médica de Santiago
publishDate 2005
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011
work_keys_str_mv AT cortesvictor nuevosreceptoresnuclearesheterodimericosreguladoresmetabolicosconimpactoenfisiopatologiaysuproyeccionterapeuticaendislipidemiasydiabetesmellitus
AT quezadanicolas nuevosreceptoresnuclearesheterodimericosreguladoresmetabolicosconimpactoenfisiopatologiaysuproyeccionterapeuticaendislipidemiasydiabetesmellitus
AT rigottiattilio nuevosreceptoresnuclearesheterodimericosreguladoresmetabolicosconimpactoenfisiopatologiaysuproyeccionterapeuticaendislipidemiasydiabetesmellitus
AT maizalberto nuevosreceptoresnuclearesheterodimericosreguladoresmetabolicosconimpactoenfisiopatologiaysuproyeccionterapeuticaendislipidemiasydiabetesmellitus
_version_ 1718436237694468096